Analysis
| Earnings estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 8 | 8 | 44 | 44 |
| Average estimate | 3.11 | 3.17 | 12.68 | 13.40 |
| Low estimate | 2.88 | 3.09 | 11.70 | 12.45 |
| High estimate | 3.30 | 3.30 | 13.70 | 15.10 |
| Last year EPS | 3.06 | 3.20 | 12.52 | 12.68 |
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 7 | 7 | 42 | 42 |
| Avg. estimate | 223.93B | 226.93B | 901.45B | 950.92B |
| Low estimate | 221.69B | 225.12B | 876.12B | 906.89B |
| High estimate | 226B | 229B | 914.58B | 980.51B |
| Last year sales | 223.02B | 223.19B | 890.88B | 901.45B |
| Sales growth | 0 | 0.02 | 0.01 | 0.05 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 3.11 | 3.17 | 12.68 | 13.40 |
| 7 days ago | 3.17 | 3.18 | 12.67 | 13.40 |
| 30 days ago | 3.11 | 3.13 | 12.68 | 13.42 |
| 60 days ago | 3.10 | 3.12 | 12.66 | 13.48 |
| 90 days ago | 3.10 | 3.12 | 12.64 | 13.43 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 1 | 2 | 4 | 4 |
| Up last 30 days | 4 | 4 | 5 | 5 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 1 | 1 | 2 | 2 |